# Use of QTRAC Technique to Measure Axonal Excitability in Anti-MAG Neuropathy

> **NCT02468596** · NA · TERMINATED · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 6 (actual)

## Conditions studied

- Peripheral Neuropathy Associated With Anti-myelin Associated Glycoprotein Antibodies (Anti-MAG Neuropathy)

## Interventions

- **OTHER:** QTRAC assessment
- **OTHER:** Clinical assessment of peripheral nerve function

## Key facts

- **NCT ID:** NCT02468596
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11
- **Primary completion:** 2019-11
- **Final completion:** 2022-02
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** lack of recruitment
- **Last updated:** 2023-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02468596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02468596, "Use of QTRAC Technique to Measure Axonal Excitability in Anti-MAG Neuropathy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02468596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*